2004
DOI: 10.1016/j.ijpharm.2004.06.003
|View full text |Cite
|
Sign up to set email alerts
|

In vitro inhibition of human neutrophil elastase by oleic acid albumin formulations from derivatized cotton wound dressings

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
32
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 59 publications
(33 citation statements)
references
References 23 publications
1
32
0
Order By: Relevance
“…Furthermore, chronic wounds often remain in the inflammatory stage for too long [32,33]. In contrast to the acute wounds' characteristic of precise balance between production and degradation of molecules such as collagen, this balance is lost and degradation plays a major role in chronic wounds [34,35]. These wounds cause patients severe emotional and physical stress and create a significant financial burden on for patients and the whole healthcare system.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, chronic wounds often remain in the inflammatory stage for too long [32,33]. In contrast to the acute wounds' characteristic of precise balance between production and degradation of molecules such as collagen, this balance is lost and degradation plays a major role in chronic wounds [34,35]. These wounds cause patients severe emotional and physical stress and create a significant financial burden on for patients and the whole healthcare system.…”
Section: Discussionmentioning
confidence: 99%
“…The metalloproteinases have degenerative effects on the structural proteins (Edwards et al, 2004). Therefore, metalloproteinase inhibitors may contribute the wound healing process.…”
Section: Methodsmentioning
confidence: 99%
“…Comparatively, human neutrophil elastase has been targeted with oleic acid/albumin formulations. 54,55 Another example of a dressing type that acts to control the microenvironment of the wound incorporates a healing accelerator, nanooligosaccharide factor, which has antiprotease properties and is released from the dressing upon contact with chronic wound fluid; this type of dressing aims to sequester the protease activity within the nonhealing wound. 56 Alternatively, Adhirajan et al 57 demonstrated the potential of modified gelatin microspheres with a catechol MMP inhibitor combined with antimicrobials incorporated into a collagen scaffold to combine the benefits of infection control and attenuation of proteases in diabetic wound tissue lysates.…”
Section: Clinical Perspective and Innovationmentioning
confidence: 99%